top
Please input keywords
Order
*Country
日本
アメリカ
中国
オーストラリア
シンガポール
イギリス
フランス
ドイツ
スイス
イタリア
カナダ
韓国
オランダ
ベルギー
スウェーデン
その他
*Province
*City
*Name
*Telephone
*Company
*Position
*Email
*Verification code
*Verification Code
B16-F10-OVA
Common name
 B16-F10-OVA Catalog number     311537
Aliases OVAL, SERPINB14  Disease  Melanoma
Organism
Mouse
Strain  C57BL/6
Tissue types Skin Tissue  Skin

Description 

The overexpression of OVA in B16-F10-OVA tumor cells can improve the immunogenicity of tumor cells and be used for screening the efficacy of immuno-oncology (I/O) therapeutics.

Application


B16-F10-OVA cells have the capability to establish tumors in vivo and can be used for efficacy studies.


Protein expression analysis



OVA expression analysis in B16-F10-OVA cells by flow cytometry. Single cell suspensions from wild-type B16-F10 and B16-F10-OVA cultures were stained with species-specific anti-OVA antibody. OVA was detected on the surface of B16-F10-OVA cells but not wild-type B16-F10 cells. The clones 1-G12 and 1-G04 of B16-F10-OVA cells were used for in vivo experiments.

Tumor growth curve & Body weight changes


Subcutaneous homograft tumor growth of B16-F10-OVA cells. B16-F10-OVA cells (2x105) and wild-type B16-F10 cells (2x105) were subcutaneously implanted into C57BL/6 mice (female, 7-week-old). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B)  Body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B16-F10-OVA cells were able to establish tumors in vivo and can be used for efficacy studies.